DEWAN SYED MAJID: Open Payments
NPI 1912391483 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 6 payments from 5 companies in 2025. Trend: 2023 $124 · 2024 $123 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $144 |
| Alkermes, Inc. | 1 | $117 |
| Janssen Pharmaceuticals, Inc | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 2 | $61 |
| ABBVIE INC. | 1 | $27 |
Products named: Auvelity, LYBALVI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across CA — which companies pay providers there.
